NCT03220776View on ClinicalTrials.gov

Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 7, 2017

Primary Completion Date

November 21, 2022

Study Completion Date

November 21, 2022

Conditions
Alcohol Use DisorderBipolar Disorder
Interventions
DRUG

N-Acetylcysteine

5 day trial of N-acetylcysteine with titration to 2,400mg

DRUG

Gabapentin

5 day trial of gabapentin with titration to 1,200mg

DRUG

Placebo Oral Tablet

5 day trial of matched placebo

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Medical University of South Carolina

OTHER

NCT03220776 - Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics | Biotech Hunter | Biotech Hunter